The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine
- PMID: 15877935
- DOI: 10.1017/S1461145705005195
The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine
Erratum in
- Int J Neuropsychopharmacol. 2005 Dec;8(4):528
Abstract
The objective of the present study was to examine the relationship between serum folate, vitamin B12, and homocysteine levels and the timing of clinical improvement to fluoxetine in major depressive disorder (MDD) patients. A total of 110 outpatients with MDD who responded to an 8-wk trial of fluoxetine had serum folate, B12, and homocysteine measurements at baseline (prior to fluoxetine initiation). Onset of clinical improvement was defined as a 30% decrease in Hamilton Depression Scale scores that led to a 50% decrease by week 8. Patients with low folate levels (<or=2.5 ng/ml) were more likely to experience a later onset of clinical improvement than eufolatemic patients ( p =0.0028). B12 and homocysteine level status did not predict time to clinical improvement ( p >0.05). In conclusion, low serum folate levels were found to be associated with a delayed onset of clinical improvement during treatment with fluoxetine in MDD by, on average, 1.5 wk.
Similar articles
-
Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 1: predictors of clinical response in fluoxetine-resistant depression.J Clin Psychiatry. 2004 Aug;65(8):1090-5. doi: 10.4088/jcp.v65n0810. J Clin Psychiatry. 2004. PMID: 15323594 Clinical Trial.
-
Folate, vitamin B12, and homocysteine in major depressive disorder.Am J Psychiatry. 1997 Mar;154(3):426-8. doi: 10.1176/ajp.154.3.426. Am J Psychiatry. 1997. PMID: 9054796 Clinical Trial.
-
Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial.J Affect Disord. 2000 Nov;60(2):121-30. doi: 10.1016/s0165-0327(00)00153-1. J Affect Disord. 2000. PMID: 10967371 Clinical Trial.
-
Treatment of depression: time to consider folic acid and vitamin B12.J Psychopharmacol. 2005 Jan;19(1):59-65. doi: 10.1177/0269881105048899. J Psychopharmacol. 2005. PMID: 15671130 Review.
-
The role of L-methylfolate in depressive disorders.CNS Spectr. 2009 Jan;14(1 Suppl 2):2-7. doi: 10.1017/s1092852900003473. CNS Spectr. 2009. PMID: 19169195 Review.
Cited by
-
Diet, Stress and Mental Health.Nutrients. 2020 Aug 13;12(8):2428. doi: 10.3390/nu12082428. Nutrients. 2020. PMID: 32823562 Free PMC article. Review.
-
Dietary Factors and Cognitive Decline.J Prev Alzheimers Dis. 2016 Mar;3(1):53-64. doi: 10.14283/jpad.2015.71. J Prev Alzheimers Dis. 2016. PMID: 26900574 Free PMC article.
-
Dietary intake of B(6-9-12) vitamins, serum homocysteine levels and their association with depressive symptoms: the Zutphen Elderly Study.Eur J Clin Nutr. 2008 Aug;62(8):939-45. doi: 10.1038/sj.ejcn.1602804. Epub 2007 May 30. Eur J Clin Nutr. 2008. PMID: 17538543
-
Predictive value of homocysteine for depression after acute coronary syndrome.Oncotarget. 2016 Oct 18;7(42):69032-69040. doi: 10.18632/oncotarget.11966. Oncotarget. 2016. PMID: 27626182 Free PMC article. Clinical Trial.
-
Prenatal methotrexate injection increases behaviors possibly associated with depression and/or autism in rat offspring; A new animal model for mental disorder, based on folate metabolism deficit during pregnancy.Neuropsychopharmacol Rep. 2022 Sep;42(3):263-271. doi: 10.1002/npr2.12255. Epub 2022 May 3. Neuropsychopharmacol Rep. 2022. PMID: 35502620 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
